Crain's Detroit Business,
6/28/2007
Ann Arbor-based Pipex Pharmaceutical Inc. has moved to the American
Stock Exchange and will launch two drugs -- one to treat multiple
sclerosis and another to treat the lung-crippling Wilson's disease.
Excerpt:
Pipex was founded in Miami in 2001 by Steve Kanzer, the company’s
chairman and CEO. A biotech investor, Kanzer moved Pipex to Michigan in
2004 to be nearer to the talent pool in Ann Arbor.
"Florida is working on its biotech industry. But there is so much more talent in Michigan, I decided to come here," he said.
Read the entire article
here.